Literature DB >> 22457297

Investing in improved performance of national tuberculosis programs reduces the tuberculosis burden: analysis of 22 high-burden countries, 2002-2009.

Yoko Akachi1, Alimuddin Zumla, Rifat Atun.   

Abstract

OBJECTIVE: To assess the impact of investment in national tuberculosis programs (NTPs) on NTP performance and tuberculosis burden in 22 high-burden countries, as determined by the World Health Organization (WHO). DATA SOURCE/STUDY
SETTING: Estimates of annual tuberculosis burden and NTP performance indicators and control variables during 2002-2009 were obtained from the Organization for Economic Cooperation and Development, the WHO, the World Bank, and the Penn World Table for the 22 high-burden countries. STUDY
DESIGN: Panel data analysis was performed using the outcome variables tuberculosis incidence, prevalence, and mortality and the key explanatory variables Partnership case detection rate and treatment success rate, controlling for gross domestic product per capita, population structure, and human immunodeficiency virus (HIV) prevalence.
RESULTS: A $1 per capita (general population) higher NTP budget (including domestic and external sources) was associated with a 1.9% (95% confidence interval, .12%-3.6%) higher estimated case detection rate the following year for the 22 high-burden countries between 2002 and 2009. In the final models, which corrected for autocorrelation and heteroskedasticity, achieving the STOP TB Partnership case detection rate target of >70% was associated with significantly (P < .01) lower tuberculosis incidence, prevalence, and mortality the following year, even when controlling for general economic development and HIV prevalence as potential confounding variables.
CONCLUSIONS: Increased investment in NTPs was significantly associated with improved performance and with a downward trend in the tuberculosis burden in the 22 high-burden countries during 2002-2009.

Entities:  

Mesh:

Year:  2012        PMID: 22457297     DOI: 10.1093/infdis/jis189

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries.

Authors:  Viviane D Lima; Reuben Granich; Peter Phillips; Brian Williams; Julio S G Montaner
Journal:  J Infect Dis       Date:  2013-08-02       Impact factor: 5.226

2.  Changes in government spending on healthcare and population mortality in the European union, 1995-2010: a cross-sectional ecological study.

Authors:  Sanjay Budhdeo; Johnathan Watkins; Rifat Atun; Callum Williams; Thomas Zeltner; Mahiben Maruthappu
Journal:  J R Soc Med       Date:  2015-10-28       Impact factor: 5.344

3.  Is health aid reaching the poor? Analysis of household data from aid recipient countries.

Authors:  Eran Bendavid
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

4.  Productivity losses associated with tuberculosis deaths in the World Health Organization African region.

Authors:  Joses Muthuri Kirigia; Rosenabi Deborah Karimi Muthuri
Journal:  Infect Dis Poverty       Date:  2016-06-01       Impact factor: 4.520

Review 5.  Addressing the Challenges of Tuberculosis: A Brief Historical Account.

Authors:  Hussam W Al-Humadi; Rafal J Al-Saigh; Ahmed W Al-Humadi
Journal:  Front Pharmacol       Date:  2017-09-26       Impact factor: 5.810

Review 6.  Primary health Centres' performance assessment measures in developing countries: review of the empirical literature.

Authors:  R Bangalore Sathyananda; A de Rijk; U Manjunath; A Krumeich; C P van Schayck
Journal:  BMC Health Serv Res       Date:  2018-08-09       Impact factor: 2.655

7.  Evaluating the impact of social support services on tuberculosis treatment default in Ukraine.

Authors:  Martha Priedeman Skiles; Siân L Curtis; Gustavo Angeles; Stephanie Mullen; Tatyana Senik
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

8.  Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries.

Authors:  Jungyeon Kim; Salmaan Keshavjee; Rifat Atun
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

9.  Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.

Authors:  Shivani Singh; Andre Kubler; Utpal K Singh; Ajay Singh; Harriet Gardiner; Rajniti Prasad; Paul T Elkington; Jon S Friedland
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

10.  Identification potential biomarkers in pulmonary tuberculosis and latent infection based on bioinformatics analysis.

Authors:  Xue-Bing Qin; Wei-Jue Zhang; Lin Zou; Pei-Jia Huang; Bao-Jun Sun
Journal:  BMC Infect Dis       Date:  2016-09-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.